Table 2 Clinical data on the patients at the time of biopsies, cohort 2: myositis patients before and after conventional immunosuppressive treatment

Patient	Age	Sex	Bohan and Peter diagnostic criteria	Treatment at time of biopsy 1, mg/day	Treatment at time of biopsy 2, mg/day
1	60	F	Definite polymyositis	None	Pred 12.5, MTX
2	23	F	Probable dermatomyositis	None	Pred 5, AZA
3	49	F	Definite dermatomyositis	NSAID	Pred 15, NSAID
4	53	F	Definite polymyositis	None	Pred 20, AZA
5	41	F	Probable dermatomyositis	None	Pred 30
6	44	F	Probable dermatomyositis	None	Pred 7.5
7	67	M	Probable polymyositis	None	Pred 10
8	88	F	Definite dermatomyositis	None	Pred 7.5
9	60	M	Probable polymyositis	NSAID	Pred 30
10	62	M	Definite dermatomyositis	None	Pred 10, AZA

AZA, azathioprine; F, female; M, male; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drugs; Pred, prednisolone.